NK1 and CGRP receptor-mediated dilatation of the carotid arterial bed of the anaesthetized rabbit

Neuropeptides

Volumn 30, Issue 2, 1996, Pages 141-148

  Perren, M J ^a   Connor, H E ^a   Beattie, D T ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; ALPHA CALCITONIN GENE RELATED PEPTIDE; BETA CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE ANTAGONIST; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN GENE RELATED PEPTIDE[8-37]; NEUROKININ 1; NEUROKININ 1 RECEPTOR; NICOTINE; SUBSTANCE P; SUBSTANCE P METHYL ESTER; TACHYKININ RECEPTOR AGONIST; UNCLASSIFIED DRUG; DRUG DERIVATIVE; SUBSTANCE P, METHYL ESTER; SUBSTANCE P, METHYL ESTER-;

ANESTHESIA; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; CAROTID ARTERY; CAROTID ARTERY FLOW; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; FEMALE; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; RABBIT; VASCULAR RESISTANCE; VASODILATATION; ANIMAL; DRUG EFFECT; PHYSIOLOGY;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

ANESTHESIA; ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CAROTID ARTERIES; FEMALE; MALE; NICOTINE; RABBITS; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; RECEPTORS, NEUROKININ-1; SUBSTANCE P; VASCULAR RESISTANCE; VASODILATION;

EID: 0029665064     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(96)90081-5     Document Type: Article

References (33)

1. Edvinsson L, Rosendal-Helgesen S, Uddman R. Substance P: localisation, concentration and release in cerebral arteries, choroid plexus and dura mater. Cell Tissue Res 1983; 234: 1-7
2. Liu-Chen L-Y, Mayberg MR, Moskowitz MA. Immunohistochemical evidence for a substance P-containing trigeminovascular pathway to pial arteries in cats. Brain Res 1983; 268: 162-166.
3. Skofitsch G Jacobowitz DM. Calcitonin gene-related peptide coexists with substance P in capsaicin sensitive neurons and sensory ganglia of the rat. Peptides 1985; 6: 747-754.
4. Goadsby PJ, Edvinsson L, Ekman R. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol 1988; 23: 193-196.
5. Moskowitz MA, Brody M, Liu-Chen L-Y. In vitro release of immunoreactive substance P from putative afferent nerve endings in bovine pia arachnoid. Neuroscience 1983; 9: 809-814.
6. Suzuki Y, Satoh S, Ikegaki I et al. Effects of neuropeptide Y and calcitonin gene-related peptide on local cerebral blood flow in rat striatum. J Cereb Blood Flow 1989; 9: 268-270.
7. Goadsby PJ. Inhibition of calcitonin gene-related peptide by h-CGRP(8-37) antagonizes the cerebral dilator response from nasociliary nerve stimulation in the cat. Neurosci Lett 1993; 151: 13-16.
8. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990; 28: 183-187
9. Moskowitz MA, Buzzi MG, Sakas DE, Linnik MD. Pain mechanisms underlying vascular headaches. Rev Neurol 1989; 145: 181-193.
10. Ikegaki I, Suzuki Y, Satoh S, Asano T, Shibuya M, Sugita K. Effects of calcitonin gene-related peptide on canine cerebral artery strips and the in vivo vertebral blood flow in dogs. Naunyn Schmiedebergs Arch Pharmacol 1989; 340: 431-436.
11. Onoue H, Nakamura N, Toda N. Endothelium-dependent and - independent responses to vasodilators of isolated dog cerebral arteries. Stroke 1988; 19: 1388-1394.
12. Beattie DT, Stubbs CM, Connor HE, Feniuk W. Neurokinin-induced changes in pial artery diameter in the anaesthetised guinea-pig. Br J Pharmacol 1993; 108: 146-149.
13. Jansen I, Uddman R, Ekman R, Oleson J, Ottosson A, Edvinsson L. Distribution and effects of neuropeptide Y, vasoactive intestinal peptide, substance P and calcitonin gene-related peptide in human middle meningeal arteries: comparison with cerebral and temporal arteries. Peptides 1992; 13: 527-536.
14. Escott KJ, Beattie DT, Connor HE, Brain SD. Trigeminal ganglion stimulation increases facial skin blood flow in the rat: a major role for calcitonin gene-related peptide. Brain Res 1995; 669: 93-99.
15. Franco-Cereceda A, Rydh M, Dalsgaard C-J. Nicotine- and capsaicin-, but not potassium-evoked CGRP release from cultured guinea-pig spinal ganglia is inhibited by ruthenium red. Neurosci Lett 1992; 137: 72-74.
16. 1 receptor antagonist. Br J Pharmacol 1991; 102: 168P.
17. Jansen I, Alafaci C, Uddman R, Edvinsson L. Evidence that calcitonin gene-related peptide contributes to the capsaicin-induced relaxation of guinea-pig cerebral arteries. Regul Pept 1990; 31: 167-178.
18. O'Shaughnessy CT, Connor HE. Activation of sensory nerves in guinea-pig isolated basilar artery by nicotine: evidence for inhibition of trigeminal sensory neurotransmission by sumatriptan. Eur J Pharmacol 1994; 259: 37-42.
19. Uddman R, Edvinsson L, Ekman R, Kingman T, McCulloch J. Innervation of the feline cerebral vasculature by nerve fibres containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett 1985; 62: 131-136.
20. Mejia JA, Pernow J, von Holst H, Rudehill A, Lundberg JM. Effects of neuropeptide Y, calcitonin gene-related peptide, substance P and capsaicin on cerebral arteries in man and animals. J Neurosurg 1988; 69: 913-918.
21. Moskowitz MA. The neurobiology of vascular head pain. Ann Neurol 1984; 16: 157-168.
22. McCulloch J, Uddman R, Kingman TA, Edvinsson L. Calcitoningene related peptide: functional role in cerebrovascular regulation. Proc Natl Acad Sci USA 1986; 83: 5731-5735.
23. Escott KJ, Beattie DT, Connor HE, Brain SD. The involvement of calcitonin gene-related peptide (CGRP) and substance P in feline pial artery diameter responses evoked by capsaicin. Neuropeptides 1995 (in press).
24. Jansen I. Characterisation of calcitonin gene-related peptide (CGRP) receptors in guinea-pig basilar artery. Neuropeptides 1995; 21: 73-79.
25. Faraci FM, Kadel KA, Heistad DD. Vascular responses of dura mater. Am J Physiol 1989; 257: 157-161.
26. McLean S, Ganong A, Seymour PA et al. Pharmacology of CP-99, 994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor. J Pharmacol Exp Ther 1993; 267: 472-479.
27. Maggi CA, Chiba T, Giuliani S. Human alpha-calcitonin gene-related peptide-(8-37) as an antagonist of exogenous and endogenous calcitonin gene-related peptide. Eur J Pharmacol 1991; 192: 85-88.
28. Okamura T, Enokibori M, Toda N. Neurogenic and non-neurogenic relaxations caused by nicotine in isolated dog superficial temporal artery. J Pharmacol Exp Ther 1993; 266: 1416-1421.
29. Toda N, Ayajiki K, Okamura T. Cerebroarterial relaxations mediated by nitric oxide derived from endothelium and vasodilator nerves. J Vasc Res 1993; 30: 61-67
30. Chen F-Y, Lee J-F. Role of nitric oxide in neurogenic vasodilation of porcine cerebral artery. J. Pharmacol Exp Ther 1993; 265: 339-345.
31. Toda N. Mediation by nitric oxide of neurally-induced human cerebral artery relaxation. Experientia 1993; 49: 51-53.
32. Ayajiki K, Okamura T, Toda N. Neurogenic relaxations caused by nicotine in isolated cat middle cerebral arteries. J Pharmacol Exp Ther 1994; 270: 795-801.
33. O'Shaughnessy CT, Waldron GJ, Connor HE. Lack of effect of sumatriptan and UK-14,304 on capsaicin-induced relaxation of guinea-pig isolated basilar artery. Br J Pharmacol 1993; 108: 191-195.